medigraphic.com
ISSN 1405-8871 (Print)

2024, Number 1

<< Back Next >>

Aten Fam 2024; 31 (1)

Prevalence of Anxiety, Depression and Social Support Networks in HIV/AIDS Patients: A Cross-Sectional Study

Secundino-Rebolledo JÁ, Sosa-Martínez MJ, Lagarza-Moreno AJ, Joanico-Morales B, Salgado-Jiménez MÁ

Language: Spanish
References: 31
Page: 12-18
PDF size: 176.35 Kb.


ABSTRACT

Objective: to determine the prevalence of anxiety, depression, and identify social support networks in patients with HIV/AIDS during the COVID-19 pandemic, in a second-level Hospital of the Mexican Institute of Social Security (IMSS). Methods: cross-sectional analytical study, 420 HIV-positive patients who attended the HIV Clinic of the grh No.1 Vicente Guerrero, in Acapulco, Mexico, from October 2021 to February 2022. A sociodemographic questionnaire was applied to obtain general information, the Gráffar-Méndez Castellanos scale, the Hospital Anxiety and Depression Scale (HADS), and the Duke. UNC-11 functional social support questionnaire. Descriptive statistics, bivariate analysis, and logistic regression by the Mantel-Haenszel process were performed with the data obtained. Results: the prevalence of anxiety was 7.1%, and depression 5.2%. 89% of the patients perceived to have sufficient total social support. An association between depression, and CD4 lymphocyte count ‹500 cells/mm3 (ORa 2.54, 95% CI 1.06-6.12) was found, as well as, insufficient perceived total social support (ORa 15.98, 95% CI 7.68-33.22). Conclusion: out of ten patients perceived to have sufficient total social support, which may be related to the low prevalence of anxiety and depression. CD4 T lymphocyte counts below 500 cells/ mm3 were associated with depression. Social support strategies and adherence to antiretroviral treatment are key to the well-being of the population living with HIV/AIDS during, and in the new normality of the COVID-19 pandemic.


REFERENCES

  1. ONUSIDA. El SIDA en cifras. Datos al cierre 2022 [Internet]. [Citado 2023 Ago 04]. Disponibleen: https://www.unaids.org/es

  2. Organización Mundial de la Salud (OMS). Datosy cifras desde 2010 a 2019 VIH [Internet]. [Citado2020 Abr 15]. Disponible en: https://www.paho.org/es/temas/vihsida

  3. Secretaría de Salud. Subsecretaría de Prevención yPromoción de la Salud. Manual de procedimientosestandarizados para la vigilancia epidemiológica dela infección por el Virus de la InmunodeficienciaHumana; 2020. [Internet]. [Citado 2020 May 2].Disponible en: https://epidemiologia.salud.gob.mx/gobmx/salud/documentos/manuales/37_Manual_VIH-SIDA_2020.pdf

  4. Shiau S, Krause KD, Valera P, Swaminathan S,Halkitis PN. The Burden of COVID-19 in PeopleLiving with HIV: A Syndemic Perspective. AIDSBehav. 2020;24(8):2244-2249.

  5. Ramírez-Ortiz J, Castro-Quintero D, Lerma-Córdoba C, Yela-Ceballos F, Escobar-Córdoba F.Mental health consequences of the COVID-19pandemic associated with social isolation. Rev ColombAnestesiol. 2020;48(4):e930.

  6. Holmes EA, O’Connor RC, Perry VH, Tracey I,Wessely S, Arseneault L, et al. Multidisciplinaryresearch priorities for the COVID-19 pandemic:a call for action for mental health science. LancetPsychiatry. 2020;7(6):547–560.

  7. Velavan TP, Meyer CG. The COVID-19 epidemic.Trop Med Int Health. 2020;25(3):278-80.

  8. Khalid I, Khalid TJ, Qabajah MR, Barnard AG,Qushmaq IA. Healthcare Workers Emotions,Perceived Stressors and Coping Strategies Duringa MERS-CoV Outbreak. Clin Med Res.2016;14(1):7-14.

  9. Jeong H, Yim HW, Song YJ, Ki M, Min JA, ChoJ, et al. Mental health status of people isolated dueto Middle East Respiratory Syndrome. EpidemiolHealth. 2016;38: e2016048.

  10. Arseniou S, Arvaniti A, Samakouri M. HIV infectionand depression. Psychiatry Clin Neurosci.2014;68(2):96–109.

  11. American Cancer Society. Infección con VIH ySIDA 2009 [Internet] [Citado 2021 Jun 20] Disponibleen: https://www.cancer.org/es/saludable/causas-del-cancer/agentes-infecciosos/infeccioncon-vih-sida/que-es-vih-y-sida.html

  12. Grupo de Expertos de la Secretaría del Plan Nacionalsobre el Sida (SPNS). Documento de consensosobre las alteraciones psiquiátricas y psicológicasen adultos y niños con infección por el virus de lainmunodeficiencia humana. Enferm Infecc MicrobiolClin. 2016;34(1):53.e1-53.e14.

  13. Mosqueda-Ramírez DE, Reyes-Pérez GDC, Montuy-Juárez Y, Miranda-de la Cruz A, Arcos-CastilloKC. Apoyo social en personas que viven con VIH.Salud, educación, sociedad y economía en la fronteraSur de México. 2017:107-123.

  14. Hargreaves J, Davey C, Group for lessons frompandemic HIV prevention for the COVID-19response. Three lessons for the COVID-19 responsefrom pandemic HIV. Lancet HIV. 2020;7(5):e309-e311.

  15. Sociedad y estratificación: método Gráffar-MéndezCastellano. Caracas FUNDACREDESA, Venezuela.1994: p206.

  16. Zigmond AS, Snaith RP. The hospital anxietyand depression scale. Acta Psychiatr Scand.1983;67(6):361-370.

  17. Herrmann, C. International experiences with theHospital Anxiety and Depression Scale: a reviewof validation data and clinical results. J PsychosomRes. 1997;42(1):17-41.

  18. Broadhead WE, Gehlbach SH, de Gruy FV, KaplanBH. The Duke-UNC Functional SocialSupport Questionnaire. Measurement of socialsupport in family medicine patients. Med Care.

  19. 1998;26(7):709-723.19. Andersson N, Mitchell S. CIETmap:free GISand epidemiology software from the CIETgroup,helping build the community voice into plannig.World Congress of Epidemiology, Montreal, Canada;August 2002.

  20. Mantel N, Haenszel W. Statistical aspects of theanalysis of data from retrospective studies of disease.J Natl Cancer Inst. 1959;22(4):719-48.

  21. Miettinen OS. Simple interval estimation of thetisk ratio. Am J Epidemiol. 1974;100:515-516.

  22. Mejía-Castrejón J, Sierra-Madero JG, Álvarez-Mota A, Muñuzuri-Najera GP, Alarcón-MurraP, Calva-Mercado JJ, et al. Consideraciones parala atención de personas que viven con VIH en elcontexto de COVID-19. Instituto Nacional deCiencias Médicas y Nutrición “Salvador Zubirán”Departamento de Infectología. 2020;1:1-36.

  23. Beltrán-De la Rosa E, Silvera-Tapia O, Armella K,Marín-Daza A, Román-Garrido A, Rojas-JiménezN. Depresión y variables asociadas al diagnósticode VIH-Sida en la población de la IPS Vital Salud.Rev Psicol GEPU. 2016;7(1):40-71.

  24. Galindo SJ, Ortega RM. Prevalencia de depresiónen pacientes con VIH/SIDA en el Hospital Generalde Zona Núm. 11 del Instituto Mexicano delSeguro Social (IMSS) “Lic. Ignacio Díaz Téllez”.Enf Inf Microbiol. 2010;30(4):129-133.

  25. Soto J, Cruz J. Depresión en pacientes con diagnósticode VIH/SIDA. Ecorfan. 2014:1-8.

  26. Betancur MN, Lins L, Oliveira IR, Brites C. Qualityof life, anxiety and depression in patients withHIV/AIDS who present poor adherence to antiretroviraltherapy: a cross-sectional study in Salvador,Brazil. Braz J Infect Dis. 2017;21(5):507-514.

  27. Moreno-Díaz J, Martínez-González A, Crespo-Redondo D, Arazo-Garcés P. Factores asociados aansiedad y depresión en pacientes VIH. Rev Multidisciplinardel SIDA. 2017;5(12):34-42.

  28. Ballivian J, Alcaide ML, Cecchini D, Jones DL,Abbamonte JM, Cassetti I. Impact of COVID-19-Related Stress and Lockdown on MentalHealth Among People Living With HIVin Argentina. J Acquir Immune Defic Syndr.2020;85(4):475-482.

  29. La depresión en los pacientes con diagnóstico deVIH/SIDA [Internet]. [Citado 2022 Nov 12].Disponible en: https://repositorio.uam.es/handle/10486/687950

  30. González-Ramírez MT, Piña-López JA. Motivos,apoyo social y comportamientos de adhesión enpersonas con VIH: modelamiento con ecuacionesestructurales. Univ Psychol. 2011;10(2):399-409.

  31. Gamba-Janota M, Hernández-Meléndrez DE,Bayarre-Vea HD. Caracterización psicológica depersonas con VIH en dos hospitales de Luanda,República de Angola. Rev Cubana Med Gen Integr.2010;26(1).




2020     |     www.medigraphic.com